Komori
Ono Pharmaceutical (4528) · RiskRestated

Legal, Regulatory, Political, and Local Environmental Risks Associated with Overseas Expansion

First written in FY2020. 1 of 2 entries say "Restated". Latest entry: FY2022.

2entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2020 – FY20222020: 120202021: 020212022: 12022
Same theme, other companies

The whole theme swung hardest in 2022: 38 of 76 companies on the "Worse" side.

38 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 113 companies compared. The sentences above are computed from all 113.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Ono Pharmaceutical's next results are scheduled for 2026-10-29. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Legal, Regulatory, Political, and Local Environmental Risks Associated with Overseas Expansion | ONO PHARMACEUTICAL CO.,LTD. (4528) | Komori